» Articles » PMID: 33547171

Functional Analysis of Immune Signature Genes in Th1* Memory Cells Links ISOC1 and Pyrimidine Metabolism to IFN-γ and IL-17 Production

Overview
Journal J Immunol
Date 2021 Feb 6
PMID 33547171
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

CCR6CXCR3CCR4CD4 memory T cells, termed Th1*, are important for long-term immunity to and the pathogenesis of autoimmune diseases. Th1* cells express a unique set of lineage-specific transcription factors characteristic of both Th1 and Th17 cells and display distinct gene expression profiles compared with other CD4 T cell subsets. To examine molecules and signaling pathways important for the effector function of Th1* cells, we performed loss-of-function screening of genes selectively enriched in the Th1* subset. The genetic screen yielded candidates whose depletion significantly impaired TCR-induced IFN-γ production. These included genes previously linked to IFN-γ or susceptibility and novel candidates, such as , encoding a metabolic enzyme of unknown function in mammalian cells. ISOC1-depleted T cells, which produced less IFN-γ and IL-17, displayed defects in oxidative phosphorylation and glycolysis and impairment of pyrimidine metabolic pathway. Supplementation with extracellular pyrimidines rescued both bioenergetics and IFN-γ production in ISOC1-deficient T cells, indicating that pyrimidine metabolism is a key driver of effector functions in CD4 T cells and Th1* cells. Results provide new insights into the immune-stimulatory function of ISOC1 as well as the particular metabolic requirements of human memory T cells, providing a novel resource for understanding long-term T cell-driven responses.

Citing Articles

Protein kinase D1 in myeloid lineage cells contributes to the accumulation of CXCR3CCR6 nonconventional Th1 cells in the lungs and potentiates hypersensitivity pneumonitis caused by .

Snyder J, Yoon T, Lee S, Halder P, Fitzpatrick E, Yi A Front Immunol. 2024; 15:1403155.

PMID: 39464896 PMC: 11502317. DOI: 10.3389/fimmu.2024.1403155.


Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses.

Yang B, Guo X, Shi C, Liu G, Qin X, Chen S mSystems. 2024; 9(11):e0081224.

PMID: 39436103 PMC: 11575419. DOI: 10.1128/msystems.00812-24.


Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive Pulmonary Disease.

Jiang M, Pang N, Wang J, Li Z, Xu D, Jing J Int J Chron Obstruct Pulmon Dis. 2023; 18:2867-2886.

PMID: 38075560 PMC: 10710255. DOI: 10.2147/COPD.S434601.


The oral bacterial microbiota facilitates the stratification for ulcerative colitis patients with oral ulcers.

Xu J, Zhang Y, Fang X, Liu Y, Huang Y, Ke Z Ann Clin Microbiol Antimicrob. 2023; 22(1):99.

PMID: 37946238 PMC: 10633958. DOI: 10.1186/s12941-023-00646-3.


Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer.

Wu Z, Li X, Gu Z, Xia X, Yang J Front Oncol. 2023; 13:1102518.

PMID: 37664033 PMC: 10470057. DOI: 10.3389/fonc.2023.1102518.


References
1.
Cheng L, Zhao Y, Tang M, Luo Z, Wang X . Knockdown of ISOC1 suppresses cell proliferation in pancreatic cancer . Oncol Lett. 2019; 17(5):4263-4270. PMC: 6444325. DOI: 10.3892/ol.2019.10082. View

2.
Ottenhoff T, Verreck F, Lichtenauer-Kaligis E, Hoeve M, Sanal O, van Dissel J . Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet. 2002; 32(1):97-105. DOI: 10.1038/ng0902-97. View

3.
Jones N, Cronin J, Dolton G, Panetti S, Schauenburg A, Galloway S . Metabolic Adaptation of Human CD4 and CD8 T-Cells to T-Cell Receptor-Mediated Stimulation. Front Immunol. 2017; 8:1516. PMC: 5684100. DOI: 10.3389/fimmu.2017.01516. View

4.
Dimitrova P, Skapenko A, Herrmann M, Schleyerbach R, Kalden J, Schulze-Koops H . Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation. J Immunol. 2002; 169(6):3392-9. DOI: 10.4049/jimmunol.169.6.3392. View

5.
Nikolova M, Marie-Cardine A, Boumsell L, Bensussan A . BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression. Int Immunol. 2002; 14(5):445-51. DOI: 10.1093/intimm/14.5.445. View